Chylous ascites is the accumulation of chyle (lymphatic fluid) in the peritoneal cavity. It can be the result of congenital defects of the lymphatic system, inflammatory processes, malignancy ...

Results from OVATION 2 Study continue to validate TheraPlas® technology, demonstrating DNA-mediated production of key anti-cancer immune cytokines following treatment IMNN-001 continues to show ...

Celonic Group, a “Pure Play” biologics contract development and manufacturing organization (CDMO), has signed a multi-year ...

New Jersey, USA-based Imunon announced new translational data from the Phase II OVATION 2 Study of IMNN-001, an ...

The results show that microbial signatures of the gut and peritoneal cavity of EM individuals significantly differ from those of the controls, whereas the cervix harbors a low-density and low-richness ...

Therefore the GE theory postulates GE incidents to start endometriosis, which thus is different from implanted endometrium. The subsequent growth in the specific environment of the peritoneal cavity ...

Data reinforce dose-dependent mechanism with IMNN-001 100mg/m2 dose associated with 20% increase in IL-12 levels compared to 79mg/m2 dose Results from OVATION 2 Study continue to validate TheraPlas® ...

Role of intraperitoneal paclitaxel in eosinophil activation and recruitment in the peritoneal cavity and anti-tumor effects against peritoneal metastasis from gastric cancer. This is an ASCO Meeting ...

A liquid biopsy analysis of exosomal miRNA to detect lymph node metastasis in early gastric cancer. Role of intraperitoneal paclitaxel in eosinophil activation and recruitment in the peritoneal cavity ...

The SUNCHIP system, which helps to regulate the temperature and flow of chemotherapy liquid in the peritoneal cavity, was developed to combine performance, simplicity, safety and economy.

Medically reviewed by Soma Mandal, MD Orthopnea is the sensation of breathlessness when lying down that goes away when sitting or standing up. It's a symptom most commonly caused by heart failure, but ...